BTBD8 antibody
Principal name
BTBD8 antibody
Alternative names for BTBD8 antibody
BTB/POZ domain-containing protein 8
SwissProt ID
Q5XKL5 (Human)
Gene ID
284697 (BTBD8)
Ncbi ID
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of BTBD8 antibody
- Kit Component:
- - KN205041G1, BTBD8 gRNA vector 1 in pCas-Guide vector
- KN205041G2, BTBD8 gRNA vector 2 in pCas-Guide vector
- KN205041D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of BTBD8 expression in transfected 293T cell line by BTBD8 MaxPab polyclonal antibody.Lane 1: BTBD8 transfected lysate(41.58 KDa).Lane 2: Non-transfected lysate.
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN205041 | BTBD8 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN205041BN | BTBD8 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN205041LP | BTBD8 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN205041RB | BTBD8 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Lysates
| Catalog No. | ||
|---|---|---|
| LY405237 | BTBD8 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC205041L2V | Lenti ORF particles, BTBD8 (mGFP-tagged) - Human BTB (POZ) domain containing 8 (BTBD8), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
| RC205041L1V | Lenti ORF particles, BTBD8 (Myc-DDK tagged) - Human BTB (POZ) domain containing 8 (BTBD8) , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€969.00
|
|
| OriGene Technologies, Inc. | ||
